NASDAQ: AMTX
Aemetis Inc Stock

$1.26-0.02 (-1.56%)
Updated Apr 30, 2025
AMTX Price
$1.26
Fair Value Price
N/A
Market Cap
$67.18M
52 Week Low
$1.22
52 Week High
$4.73
P/E
-0.66x
P/B
-0.25x
P/S
0.46x
PEG
N/A
Dividend Yield
N/A
Revenue
$267.64M
Earnings
-$87.54M
Gross Margin
-0.2%
Operating Margin
-19.33%
Profit Margin
-32.7%
Debt to Equity
-1.98
Operating Cash Flow
-$33M
Beta
2.05
Next Earnings
May 7, 2025
Ex-Dividend
N/A
Next Dividend
N/A

AMTX Overview

Aemetis, Inc. operates as a renewable natural gas and renewable fuels company in North America and India. It operates through three segments: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products. It sells biodiesel primarily to government oil marketing companies, transport companies, resellers, distributors, and private refiners through its own sales force and independent sales agents, as well as to brokers who resell the product to end-users. The company also produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. In addition, it produces dairy biogas; produces and sells high-grade alcohol and various feed products, as well as hand sanitizers; and researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. The company was formerly known as AE Biofuels, Inc. and changed its name to Aemetis, Inc. in November 2011. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine AMTX's potential to beat the market

FStrong Sell
  • Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More

Zen Rating Component Grades

D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Oil & Gas Refining & Marketing

Industry Rating
F
AMTX
Ranked
#20 of 22

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$12.45A
$23.83B
$3.15C
View Top Oil & Gas Refining & Marketing Stocks

Be the first to know about important AMTX news, forecast changes, insider trades & much more!

AMTX News

Overview

Due Diligence Score

Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AMTX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AMTX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AMTX is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
AMTX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more AMTX due diligence checks available for Premium users.

Valuation

AMTX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.66x
Industry
21.73x
Market
29.18x

AMTX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
-0.25x
Industry
1.67x

AMTX's financial health

Profit margin

Revenue
$47.0M
Net Income
-$16.2M
Profit Margin
-34.5%
AMTX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
AMTX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$259.3M
Liabilities
$523.2M
Debt to equity
-1.98
AMTX's short-term liabilities ($143.97M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AMTX's long-term liabilities ($379.26M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AMTX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AMTX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$12.6M
Investing
-$3.7M
Financing
$16.8M
AMTX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

AMTX vs Oil & Gas Refining & Marketing Stocks

TickerZen RatingMarket Cap1d %P/EP/B
AMTXF$67.18M-1.56%-0.66x-0.25x
PTLE$14.88M+5.31%N/A8.90x
BPT$11.77M+1.66%N/A3.25x
CLNEC$324.23M0.00%-3.92x0.45x
SGUA$430.36M+1.06%9.73x1.48x

Aemetis Stock FAQ

What is Aemetis's quote symbol?

(NASDAQ: AMTX) Aemetis trades on the NASDAQ under the ticker symbol AMTX. Aemetis stock quotes can also be displayed as NASDAQ: AMTX.

If you're new to stock investing, here's how to buy Aemetis stock.

What is the 52 week high and low for Aemetis (NASDAQ: AMTX)?

(NASDAQ: AMTX) Aemetis's 52-week high was $4.73, and its 52-week low was $1.22. It is currently -73.36% from its 52-week high and 3.28% from its 52-week low.

How much is Aemetis stock worth today?

(NASDAQ: AMTX) Aemetis currently has 53,319,340 outstanding shares. With Aemetis stock trading at $1.26 per share, the total value of Aemetis stock (market capitalization) is $67.18M.

Aemetis stock was originally listed at a price of $5.83 in May 16, 2014. If you had invested in Aemetis stock at $5.83, your return over the last 10 years would have been -78.37%, for an annualized return of -14.2% (not including any dividends or dividend reinvestments).

How much is Aemetis's stock price per share?

(NASDAQ: AMTX) Aemetis stock price per share is $1.26 today (as of Apr 30, 2025).

What is Aemetis's Market Cap?

(NASDAQ: AMTX) Aemetis's market cap is $67.18M, as of May 2, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Aemetis's market cap is calculated by multiplying AMTX's current stock price of $1.26 by AMTX's total outstanding shares of 53,319,340.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.